UNSPSC 51434925: Deserpidine/hydrochlorothiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434925 Deserpidine/hydrochlorothiazide is a Commodity code with minimal recent state and local procurement activity. The single recent solicitation indexed under this code—Tampa Fire Rescue's April 2026 bid for Advanced Life Support Medications (IFB 26P00188)—does not align with the code's nominal pharmaceutical scope. The solicitation actually seeks four distinct acute-care medications (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem) for emergency medical use, none of which correspond to deserpidine/hydrochlorothiazide, a combination antihypertensive agent used in chronic blood-pressure management. The mismatch suggests either miscoding at the jurisdiction level or a tagging error in the state and local procurement data feed.

The City of Tampa's purchasing office posted the only recent indexed opportunity on April 24, 2026, with electronic bids due April 8, 2026, through the OpenGov eProcurement Portal. The contract carried a $40,000 estimated value, a one-year base term with two optional one-year renewals plus three optional 30-day extensions, and a 5 percent bid discount for Small Local Business Enterprise (SLBE) participation not to exceed $10,000. Award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening. All vendors were required to provide Safety Data Sheets compliant with OSHA Hazard Communication Standards and comprehensive accessibility documentation demonstrating WCAG 2.2 Level AA and Section 508 compliance. Given the absence of other recent state and local opportunities under this code and the categorical mismatch between the code name and the solicitation scope, this Commodity code shows no substantive activity for business development purposes.